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Serotonin (5-HT) plays an important role in the modulation of behavior across animal
species. The serotonin 1A receptor (Htr1a) is an inhibitory G-protein coupled receptor
that is expressed both on serotonin and non-serotonin neurons in mammals. Mice lacking
Htr1a show increased anxiety behavior suggesting that its activation by serotonin has an
anxiolytic effect. This outcome can be mediated by either Htr1a population present on
serotonin (auto-receptor) or non-serotonin neurons (hetero-receptor), or both. In addition,
both transgenic and pharmacological studies have shown that serotonin acts on Htr1a
during development to modulate anxiety in adulthood, demonstrating a function for this
receptor in the maturation of anxiety circuits in the brain. However, previous studies have
been equivocal about which Htr1a population modulates anxiety behavior, with some
studies showing a role of Htr1a hetero-receptor and others implicating the auto-receptor.
In particular, cell-type specific rescue and suppression of Htr1a expression in either
forebrain principal neurons or brainstem serotonin neurons reached opposite conclusions
about the role of the two populations in the anxiety phenotype of the knockout. One
interpretation of these apparently contradictory findings is that the modulating role of
these two populations depends on each other. Here we use a novel Cre-dependent
inducible allele of Htr1a in mice to show that expression of Htr1a in cortical principal
neurons is sufficient to modulate anxiety. Together with previous findings, these results
support a hetero/auto-receptor interaction model for Htr1a function in anxiety.
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INTRODUCTION
The major inhibitory serotonin (5-HT) receptor, serotonin 1A
receptor (Htr1a), is found in the brain in two distinct pop-
ulations, autoreceptors and heteroreceptors. Auto-receptors are
expressed on serotonin neurons in the raphe nuclei and provide a
regulatory feedback loop by inhibiting the firing rate of serotonin
cells (Pompeiano et al., 1992; Blier et al., 1998; Evrard et al., 1999).
Heteroreceptors are expressed widely in the brain, including
cortex, amygdala and hippocampus, on non-serotonin neurons
(Pompeiano et al., 1992; Casanovas et al., 1999). Mice lacking the
Htr1a gene show increased anxiety and stress responses in a num-
ber of behavioral tests (Ramboz et al., 1998; Bonasera and Tecott,
2000; Ase et al., 2002; Toth, 2003). On the other hand, pharma-
cological activation of Htr1a receptors reduces anxiety (File and
Gonzalez, 1996) and Htr1a agonists have been used successfully
in the clinic to treat anxiety disorders (Artigas et al., 1996; Lader
and Scotto, 1998; Trivedi et al., 2006). In humans, positron emis-
sion tomography studies show correlations between trait anxiety
and lower HTR1A binding (Albert, 2012). Likewise such correla-
tions have also been seen for other mental traits (Meltzer et al.,
2004; Neumeister et al., 2004; Spindelegger et al., 2009; Shrestha
et al., 2012).Moreover, a common genetic variant in the promoter
of HTR1A in humans, that is thought to reduce its expression,
is associated with suicide and depression (Lemonde et al., 2003;
Parsey et al., 2006). Findings from tissue-specific injections of
Htr1a agonists in rodents suggest that different populations of
Htr1a may have opposing roles in anxiety modulation, as agonists
injected into the hippocampus or amygdala are anxiogenic, while
injections into the raphe are anxiolytic (File et al., 1996; Gonzalez
et al., 1996; Akimova et al., 2009).
Cell-type specific manipulation of Htr1a in transgenic mice
has been a powerful approach to examine the role Htr1a in anx-
iety and to define the cell-types and circuits involved. Previous
studies testing the role of Htr1a hetero-receptors on anxiety either
used expression of Htr1a under control of the Camk2a promoter
on an otherwise knockout background (Gross et al., 2002) or used
the suppression of endogenous Htr1a in Camk2a-expressing cells
(Richardson-Jones et al., 2011). The first study showed that rescue
of Htr1a expression was able to reverse the anxiety phenotype of
the knockout, while in the latter no effect of suppression of Htr1a
expression on anxiety behavior was seen. However, concerns
raised in the first investigation by the ectopic expression of Htr1a
(e.g., in striatal principal neurons) rendered direct comparison
of both studies difficult. Here we developed a new conditional
rescue allele of Htr1a and used it to test the role of Htr1a hetero-
receptors in anxiety. We show that increasing Htr1a3 expression
selectively in cortical principal neurons is associated with decreas-
ing anxiety in mice. These data demonstrate that Htr1a impacts
anxiety at least in part by modulating cortical function.
MATERIALS AND METHODS
GENE TARGETING
Genomic sequence harboring the Htr1a coding sequence and
5′UTR was amplified using tail genomic DNA from C57BL/6N
Frontiers in Behavioral Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 48 | 1
BEHAVIORAL NEUROSCIENCE
Piszczek et al. Anxiety modulation by cortical Htr1a
mice and cloned into a pcDNA3 expression plasmid (Invitrogen,
Carlsbad, CA, USA). The tdTomato coding sequence (Silva et al.,
2013) was amplified from pRSET-B-tdTomato (kindly provided
by Roger Tsien, University of California, San Diego, USA) and
cloned downstream of the Htr1a open reading frame separated by
a P2A sequence (Holst et al., 2006). The pBS-XZ/keo/STOP/tetO
cassette (kindly provided by Xiao Xi Zhuang, University of
Chicago, USA) was subcloned upstream of the Htr1a open read-
ing frame and 5′ and 3′ homology arms were introduced flanking
the construct. A genomic fragment containing the Htr1a locus
was retrieved from a 220 kb mouse BAC (RP23-146M15, Chori-
BACPAC Resources, Oakland, USA) using recombineering. The
entire STOP-Htr1a-P2A-tdTomato cassette was then recombined
into the retrieved sequence and the resulting construct used to
target mouse embryonic stem cells.
cAMP ASSAY
Chinese hamster ovary (CHO) cells (2.5 × 106) were seeded on
a 10mm diameter dish. After 24 h cells were transfected accord-
ing to the manufacturer’s instructions (FuGENE HD; cat. no.
0470969100; Roche Diagnostics GmbH, Mannheim, Germany)
with (1) pmaxGFP (kindly provided by Paul Heppenstall, EMBL),
(2) pcDNA3-Htr1a-P2A-tdTomato, or (3) a mixture of pmaxGFP
and pcDNA3-Htr1a. Forty 8 h later cells were harvested by
trypsinization, resuspended in single cell suspension and sorted
by FACS using GFP (1 and 3) or tdTomato (2) channels. Fifteen
thousand cells were seeded per well in a 96-well plate. Eighteen
hours later cAMP assay was performed using cAMP-Glo kit
according to manufacturer instruction (PromegaMadison, USA).
WESTERN BLOTTING
CHO cells were seeded and transfected 24 h afterwards with
either empty pcDNA3 vector, pcDNA3-Htr1a-P2A-tdTomato
or pcDNA3-Htr1a-P2A∗-tdTomato, according to manufacturer
instructions (FuGENE HD; Roche Diagnostics, Mannheim,
Germany). Cells were collected by trypsinization, centrifuged
and washed twice with ice cold PBS and resuspended in hot
4x Laemmli buffer (0.22M Tris-HCl, pH 6.8; 4.4% SDS; 5%
β-mercaptoethanol; 44% glycerol; 0.05% bromophenol blue),
boiled at 95◦C for 10min and passed at least 5 times through
1ml syringe. The protein extract was stored at -80◦C until used.
Western blotting was performed as described previously (Lo
Iacono and Gross, 2008) using 1:1000 Living Colors® DsRed
(Takara Bio Europe/Clontech, Saint-Germain-en-Laye, France)
primary antibody for detection of tdTomato and 1:4000 sec-
ondary HRP-conjugated rabbit IgG antibody (NA934 Amersham
Biosciences, Otelfingen, Switzerland). The blots were then re-
analyzed using 1:5000 α-actin primary antibody (Millipore,
Billerica, USA) and HRP-coniugated mouse IgG antibody
(NA931 Amersham Biosciences, Otelfingen, Switzerland).
Htr1acR MOUSE LINE GENERATION
The Htr1a targeting construct was electroporated into A9 ES cells
(Nakashima et al., 2011; C57BL/6x129/Sv) kindly provided by
Donal O’Carroll (EMBL) and Anton Wutz (ETH, Switzerland).
Southern blot was used to detect proper integration of the con-
struct. Positive clones were injected into C57BL/6 8-cell-stage
embryos for generation of fully ES-cell-derived mice as described
elsewhere (De Fazio et al., 2011). ES-cell-derived mice were
bred with C57BL/6 mice for >5 generations to establish the
Htr1acR line. To obtain our behavioral cohorts, both Emx1-Cre
(Emx1Cre/+,Iwasato et al., 2000, 2004; >6 generations C57BL/6)
and Htr1a-cR (Htr1acR/+) lines were crossed with the consti-
tutive Htr1a knockout line (Htr1aKO/KO; Ramboz et al., 1998;
congenic C57BL/6, Lo Iacono and Gross, 2008). The offspring
were intercrossed (Emx1Cre/+; Htr1aKO/+ × Htr1acR/KO) to pro-
duce the parents (Emx1Cre/+; Htr1acR/KO × Htr1acR/KO) of the
behavioral cohorts: (1) Emx1Cre/+; Htr1acR/cR, (2) Emx1+/+;
Htr1acR/cR, (3)Emx1Cre/+; Htr1aKO/KO, and (4) Emx1+/+;
Htr1aKO/KO. The genetic background of the mice analyzed in
the behavioral part of the study were thus >6 generations back-
crossed to C57BL/6. Care was taken to exclude transgenic animals
(36% of Cre+, cKO+ mice) in which Cre-mediated deletion of
the cKO cassette was detected in blood and that presumably
had undergone widespread deletion (Iwasato et al., 2004; Zeller
et al., 2008). Such deletion was seen predominantly in offspring
in which the transgenes were inherited via the father, and may
be due to activity of Emx1-Cre in the male germline. Breedings
between heterozygous Htr1a knockout mice that were siblings
of the animals described above were carried out in parallel to
obtain wild-type and knockout littermates for gene expression
and behavioral testing.
OTHER MOUSE LINES USED IN THE STUDY
The Emx1-Cre line (Iwasato et al., 2000, 2004), kindly provided
by Dr. Takuji Iwasato, was crossed to a FLP-deleter strain (Farley
et al., 2000; congenic C57BL/6) in order to excise the Neo cassette,
which has been reported to drive ectopic expression (Iwasato
et al., 2004). The line was then further backcrossed to C57BL/6
for>5 generations. The HPRTCre-deleter line (Tang et al., 2002),
kindly provided by Francois Spitz (EMBL), and Slc6a4mtTA/+ ani-
mals (Audero et al., 2008), kindly provided by Enrica Audero,
were maintained on a mixed 129S6/SvEvTac;C57BL/6;CBA back-
ground.
ANIMAL HUSBANDRY
Animals were housed in groups of two to four per cage with
ad libitum access to food and water. Animals were maintained on
a 12:12 light/dark schedule (lights on at 7:00, off at 19:00). All
testing was conducted during the light period. All experiments
followed protocols approved by the ItalianMinistry of Health and
were carried out in accordance with the European Communities
Council Directive of 24 November 1986 (86/609/EEC).
RADIOLIGAND BINDING
Mice were sacrificed by cervical dislocation and decapitation.
Extracted brains were frozen immediately on dry ice and
kept at -80◦C until sectioning. Tissue was cryosectioned at
18μm and thaw-mounted on glass slides (Superfrost, Fisher
Scientific, Pittsburgh, USA). The slides were kept at -80◦C
until further processing. Receptor expression was assessed by
incubation with 4-(2-methoxyphenyl)-1-[2-(n-2′′-pyridinyl)-p-
[125I]iodobenzamido]ethylpiperazine (125I-MPPI, Perkin-Elmer,
Waltham, USA) washing briefly with water followed by exposure
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to a film and quantitative autoradiography as previously
described (Piszczek et al., 2013). For validating expression by
Cre-deleter mediated excision two to four animals per group
(Htr1acR/cR, Htr1acR/cR;HprtCre/+,Htr1a+/+, and Htr1aKO/KO)
and 3–12 sections per animal were quantified and averaged. For
validating expression following Emx1-Cre mediated excision five
to eight animals per group (Htr1acR/cR, Htr1acR/cR;Emx1Cre/+,
Htr1a+/+, and Htr1aKO/KO) and 3–12 sections per animal were
quantified and averaged.
IMMUNOFLUORESCENCE
Mice were anesthetized intraperitoneally with Avertin (Sigma-
Aldrich, St Louis, USA) and perfused transcardially with 4%
paraformaldehyde. Brains were postfixed overnight at 4◦C and
sectioned on a vibratome (70μm; Leica Microsystems, Wetzlar,
Germany). Free floating sections were stained with primary anti-
bodies overnight at 4◦C (1:1000 mouse α-GAD67, Millipore,
Billerica, USA; 1:1000 rabbit α-RFP, Rockland Immunochemicals
Inc., Gilbertsville, USA) and incubated with secondary anti-
bodies (2 h at room temperature; mouse IgG A488 or rab-
bit IgG A594, Molecular Probes/Invitrogen, Carlsbad, USA).
Confocal microscopy was performed with a TCS-SP5 (Leica)
Laser Scanning System. The images were processed using the
ImageJ software (NIH, Bethesda, MD).
BEHAVIORAL TESTING
Mice were tested at 8–12 weeks of age, unless otherwise indicated.
For all tests both males and females were used. Behavioral tests
were separated by 1 week intervals to reduce inter-test interac-
tions. The open field test was carried out as previously described
(Lo Iacono and Gross, 2008; Piszczek et al., 2013) and lasted
45min. Dependent measures were: total distance traveled, per-
centage of distance in the center (distance traveled in the center
divided by the total distance traveled), and time spent in the cen-
ter and were scored automatically by a videotracking system (TSE
Systems, Bad Homburg, Germany). The elevated plus maze test
was carried out as previously described (Piszczek et al., 2013)
and lasted 5min. Initially, mice were placed in the central plat-
form facing a closed arm and behavioral measures (time spent in
open arms, time spent in closed arms, percentage of distance trav-
eled in open arms, and total distance traveled) were scored using
a videotracking system (TSE Systems) or scored manually (head
dips). The light/dark test was performed in a similar manner as
described elsewhere (Klemenhagen et al., 2006). For this test the
same apparatus as for the open field was used, with the following
modifications: to each open field apparatus a black, opaque box
was inserted with height and width allowing tight insertion and
having half the length of the open field box, with an opening in
themiddle of the box to allowmouse access. The setup was illumi-
nated indirectly with two 500Wwhite lamps, resulting in 150-170
lux in the light compartment. The test lasted 20min. Dependent
measures were: distance traveled in light compartment, time
spent in the light compartment, number of transitions between
light and dark compartments and were scored automatically by a
videotracking system (TSE Systems). The tail suspension test was
carried out as previously described (Carola et al., 2008). To avoid
tail climbing that is frequent in female mice a short section of
plastic tubing (cut from 15ml tube) was placed over the tail of all
animals. Periods of immobility were scored manually for 6min.
STATISTICAL ANALYSIS
In general, analysis of behavioral and physiological responses
was performed using Prism 4 software (GraphPad Software, San
Diego, USA). The effect of genotype was assessed by ANOVA
using repeated measures when appropriate or Student t-test.
In case of significance ANOVA was followed by Tukey’s multi-
ple comparison post hoc test to compare individual genotypes.
The effect of 8-OH-DPAT on cAMP levels in cells was analyzed
by Two-Way ANOVA and followed in cases of significance by
Bonferroni post hoc test.
RESULTS
DESIGN OF Cre AND tTA-INDUCIBLE Htr1a ALLELE
To create a Cre-inducible Htr1a allele (Figure 1A; cR; Htr1acR)
a loxP-flanked transcriptional STOP cassette (His3-SV40pA
sequence; Lakso et al., 1992; Sauer, 1993) was inserted into the
5′UTR of the Htr1a gene in embryonic stem cells via gene tar-
geting. To allow tTA-dependent transactivation of Htr1a from the
same allele, a tetracycline operator (7xtetO) was placed upstream
of the STOP cassette (Lewandoski, 2001). To fluorescently tag cells
expressingHtr1a, a tdTomato protein was fused to the C-terminus
of Htr1a via a self-cleaving P2A sequence (Shaner et al., 2004;
Szymczak et al., 2004; Holst et al., 2006; Shuen et al., 2008).
IN VITRO TESTING OF Htr1a-P2A-tdTOMATO FUNCTIONALITY
The P2A sequence has been successfully used before in both
in vitro and in vivo experiments for multi-cistronic expres-
sion of proteins, resulting in their post-translational separation
(Szymczak et al., 2004; Holst et al., 2006). However, this fea-
ture was first tested with our Htr1a constructs. CHO cells were
transfected with expression vectors carrying either a Htr1a-P2A-
tdTomato (P2A) construct or a modified version in which the
P2A sequence had been mutated to a non-cleavable form (∗P2A;
Szymczak et al., 2004). The cleavage was then assessed byWestern
Blot using an anti-dsRed antibody that recognizes tdTomato.
As expected, the translation product of the cleavable form has
migrated faster than its non-cleavable counterpart, indicating its
lower molecular weight (Figure 1B). This result suggests separa-
tion of the tdTomato from Htr1a in vitro.
Htr1a receptors are negatively coupled to adenylyl cyclase and
their activation results in reduction of intracellular cAMP levels
(Fargin et al., 1989). The 18 amino acid peptide left on the C-
terminus of Htr1a protein by P2A cleavage could possibly impair
receptor functionality. To test this possibility the wild-type Htr1a
receptor or Htr1a-P2A-tdTomato was expressed in CHO cells
and the change in forskolin-induced cAMP levels upon expo-
sure to the Htr1a agonist 8-OH-DPAT (Figure 1C) was measured.
Two-Way ANOVA (treatment-by-group) revealed a significant
main effect of treatment [F(2, 30) = 64.83, P < 0.0001], group
[F(2, 30) = 72.99, P < 0.0001], and treatment-by-group interac-
tion [F(4, 30) = 19.95, P < 0.0001]. There was no statistically
significant effect for vehicle treatment between groups (post-hoc,
P > 0.05) and no effect of drug on the cells transfected with
empty vector (post-hoc, P > 0.05).
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FIGURE 1 | Cre/tTA-inducible and Tomato-tagged allele of Htr1a. (A)
An overview of the Htr1acR mouse line showing the loxP-flanked
transcriptional stop cassette targeted to the 5′ UTR of Htr1a and the
tdTomato reporter fused to the C-terminus of Htr1a via the self-cleaving
P2A peptide. (B) Western blot probed with anti-RFP or anti-Actin control
antibodies of extracts from CHO cells transfected with
Htr1a-P2A-tdTomato or uncleavable Htr1a-∗P2A-tdTomato plasmid revealed
the expected cleaved P2A-tdTomato band and uncleaved
Htr1a-∗P2A-tdTomato band, respectively. (C) Quantification of
forskolin-induced cAMP levels in CHO cells transfected with Htr1a or
Htr1a-P2A-tdTomato plasmid and treated with low or high dose of the
selective Htr1a agonist 8-OH-DPAT revealed a similar dose-dependent
blockade by agonist treated wild-type or tagged Htr1a (N = 4–5, mean ±
SD, ∗P < 0.05, ∗∗∗P < 0.001).
CREATION AND VALIDATION OF Htr1acR ALLELE
Next, murine ES cells were targeted with the targeting construct
shown in Figure 1A, selected positive clones, and piezo-drill
assisted morula injection was used to generate mice carrying
the Cre/tTA-conditional Htr1acR allele. Htr1acR/cR mice were
then crossed to the Hprt-Cre line (Tang et al., 2002) to remove
the loxP-flanked STOP cassette. Autoradiography was then used
to quantify Htr1a protein expression in tissue sections of the
resulting ubiquitous rescue mice (Htr1acR/cR; HprtCre/+) and
non-Cre carrying littermates (Htr1acR/cR) (Figure 2A). Excision
of the STOP cassette resulted in Htr1a protein expression in
a pattern indistinguishable from that seen in wild-type mice.
Interestingly, Htr1a expression inHtr1acR/cR;HprtCre/+ mice was
lower than that seen in wild-type animals suggesting that the
remaining exogenous sequences in the Htr1a locus (e.g., loxP,
P2A-tdTomato, etc.) impeded full expression of Htr1a. Moreover,
Htr1a protein was also detected at low levels in the non-Cre
carrying Htr1acR/cR littermates indicating that the STOP cas-
sette did not completely block Htr1a transcription (Figure 2B).
Importantly, the expression pattern in the Htr1acR/cR animals
was indistinguishable from that seen in wild-type mice, suggest-
ing that it was driven by endogenous Htr1a regulatory sequences.
Nevertheless, quantification of Htr1a binding confirmed a sig-
nificant effect of genotype in cortex [ANOVA, main effect of
genotype: F(3, 11) = 58.14, P < 0.0001], hippocampus [ANOVA,
main effect of genotype: F(3, 10) = 56.13, P < 0.0001], and dor-
sal raphe [ANOVA, main effect of genotype: F(3, 8) = 25.37, P =
0.0002]. In addition, the Htr1acR/cR line was crossed to a Flp-
deleter transgenic line (Farley et al., 2000) to investigate whether
the FRT-flanked neomycin selection cassette was responsible for
the leakiness of the STOP cassette. Expression analysis demon-
strated that deletion of the neomycin gene cassette resulted in
higher rather than lower tdTomato and Htr1a expression (data
not shown) arguing against a contribution of the neomycin gene
to leakiness. Finally, the Htr1acR line was crossed with the Slc6a4-
tTA line (Audero et al., 2008) to assess tTA-inducible expression
of Htr1a (Figure 2D). As expected, expression of Htr1a was
significantly induced in raphe nuclei (Figure 2E).
CELL-TYPE SPECIFIC Htr1a EXPRESSION IN Htr1aR MICE
Consistent with expression of Htr1a restricted to principal cells in
cortical structures, tdTomato expression in the hippocampus of
ubiquitous rescue mice (named Htr1aR, Htr1acR/cR; HprtCre/+),
was restricted to pyramidal and granule cells in the CA1 and
dentate gyrus, respectively (Figures 3A,B). However, in the raphe
nuclei Htr1a expression has been reported in both serotonergic
and GABAergic neurons (Bonnavion et al., 2010) with the latter
being suspected to provide inhibitory input to serotonin neurons
(Wang et al., 1992; Gervasoni et al., 2000) and receive glutamater-
gic inputs from forebrain regions (Hajós et al., 1998, 2003, 1999;
Boothman and Sharp, 2005). Consistent with the expression of
Htr1a autoreceptors and heteroreceptors in the raphe, tdTomato
expression in the analyzedmice was observed in both serotonergic
and GABAergic neurons in the lateral wings of the dorsal raphe,
while in the midline it was restricted to serotonergic neurons
(Figure 3C).
CORTEX-SPECIFIC INCREASE OF Htr1a EXPRESSION IS ASSOCIATED
WITH DECREASED ANXIETY
Our earlier data suggested that expression of Htr1a in forebrain
principal neurons was sufficient to reverse the increased anxiety
phenotype of Htr1a knockout mice (Gross et al., 2002). However,
more recent data showed that suppression of Htr1a expression
in forebrain principal neurons of wild-type mice did not alter
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FIGURE 2 | Cre- and tTA-inducible expression of Htr1a. (A)
Cre-mediated excision of the STOP cassette in Htr1acR mice allows
expression of Htr1a from its native promoter. (B) Representative
autoradiographs of 125I-MPPI binding to coronal mouse brain sections
containing septum (top), hippocampus (middle), and raphe (bottom) from
adult wild-type (Htr1a+/+), knockout (Htr1aKO/KO), conditional rescue
(Htr1acR/cR), and constitutive rescue (Htr1acR/cR; HprtCre/+) mice. (C)
Quantification of normalized 125I-MPPI signal in auditory cortex (Cortex),
CA1 hippocampus (Hippocampus) and dorsal raphe (Raphe) confirmed
increased expression of Htr1a in the constitutive rescue as compared to
the conditional rescue line (N = 2 − 4; mean ± SEM, ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001; asterisks above bars indicate P-value vs.
wild-type). (D) tTA-mediated activation of transcription in Htr1acR mice
allows expression of Htr1a from a heterologous promoter. (E)
Representative autoradiographs of 125I-MPPI binding to coronal mouse
brain sections containing septum, hippocampus, and raphe nuclei from
adult animals expressing tTA in serotonin neurons (Htr1acR/+;
Slc6a4mtTA/+) revealed increased Htr1a expression in raphe nuclei, but
not septum, cortex, or hippocampus when compared to control
littermates (Htr1acR/+; Slc6a4+/+).
anxiety behavior, and it has been argued that ectopic expres-
sion of Htr1a in the original study may have been responsible
for the rescue phenotype and the apparent discrepancy between
these findings (Richardson-Jones et al., 2011). An alternative pos-
sibility is that Htr1a expression in principal forebrain neurons is
sufficient, but not necessary to modulate anxiety (Piszczek et al.,
2013). To test this hypothesis Htr1acR/cR animals were crossed to
Emx1-Cre transgenic mice (Emx1Cre; Iwasato et al., 2000) in order
to increase Htr1a expression selectively in principal cortical neu-
rons and examine whether expression of Htr1a under control of
its endogenous promoter in this cell-type was sufficient to mod-
ulate anxiety behavior. As expected, double transgenic animals
(Htr1acR/cR; Emx1Cre/+) showed increased expression of Htr1a
in cortex and hippocampus, but not in raphe nuclei when com-
pared to non-Cre expressing littermates (Figure 4A). Increased
expression was also observed in other cortical-related structures,
such as basolateral amygdala. Importantly, no ectopic Htr1a
expression was detected. Quantification of the signal (Figure 4C)
showed a significant genotype effect onHtr1a expression in cortex
[ANOVA, main effect of genotype: F(3, 24) = 76.98, P < 0.0001],
hippocampus [ANOVA,main effect of genotype: F(3, 25) = 70.28,
P < 0.0001], and dorsal raphe nucleus [ANOVA, main effect of
genotype: F(3, 20) = 45.79, P < 0.0001]. Finally, increased Htr1a
expression in hippocampus and cortex was also seen at postnatal
day 15 (Figure 4B), the critical period in which Htr1a is required
for the modulation of the adult anxiety phenotype (Gross et al.,
2002; Lo Iacono and Gross, 2008).
Next, anxiety behavior in adult cortical rescue (Htr1acR/cR;
Emx1Cre/+) and control (Htr1acR/cR; Emx1+/+) mice was mea-
sured. To be able to directly compare behavioral results from these
mice with those of constitutive Htr1a knockout mice (Htr1aKO;
Ramboz et al., 1998) Htr1a knockout littermates with and with-
out the Emx1Cre allele (Htr1aKO/KO; Emx1Cre/+ and Htr1aKO/KO;
Emx1+/+) were included as controls. A significant effect of geno-
type was found on time in the open arms [Figure 5B; ANOVA,
main effect of genotype: F(3, 108) = 5.284, P = 0.0019] and num-
ber of head dips [Figure 5C; ANOVA, main effect of genotype:
F(3, 108) = 10.30, P < 0.0001] in the elevated plus maze. Cortex-
specific rescue animals (Htr1acR/cR; Emx1Cre/+) spent more time
and performed more head dips, respectively, than their Cre-
negative (Htr1acR/cR; Emx1+/+) littermates. No genotype effect
on total locomotion [Figure 5A; ANOVA, main effect of geno-
type: F(3, 108) = 0.05335, P = 0.9837] was detected. Importantly,
no significant effect of the Cre transgene alone on behavior
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FIGURE 3 | Cell-type specific gene expression in Htr1aR mice.
Immunohistochemistry revealed tdTomato reporter protein expression in
(A) CA1 pyramidal cells of the hippocampus and (B) granule cells and
processes of the outer molecular layer of the dentate gyrus in Htr1aR
(Htr1acR/cR; HPRTCre/+), but not wild-type mice. Note the preferential
expression in the ventral portion of the CA1 pyramidal layer (tdTomato
positive cell indicated by an yellow arrow; scale bar = 50μm; higher
magnification shown in (C) and in scattered cells in the hilus of the
dentate gyrus (tdTomato negative cell indicated by an white arrow; scale
bar = 50μm). Overall anatomy is highlighted by DAPI counterstain (blue)
in lower panels. (D) Double-immunofluorescence for the GABAergic
marker Gad67 and tdTomato reporter protein revealed co-labeled cells in
the lateral wings, but not midline of the dorsal raphe nucleus (orange
arrows; scale bar = top 100μm, middle and lower = 40μm) Single
labeled cells are marked as white arrowheads (Gad76) or white arrows
(tdTomato).
(Htr1aKO/KO; Emx1Cre/+ vs. Htr1aKO/KO; Emx1+/+, P > 0.05
for all parameters analyzed) was detected. Moreover, a signifi-
cant genotype effect was seen on distance traveled in the light
compartment [Figure 5D; ANOVA, main effect of genotype:
F(3, 86) = 5.629, P = 0.0014] as well as number of transitions
between dark and light compartments [Figure 5F; ANOVA, main
effect of genotype: F(3, 86) = 3.504, P = 0.0188] in the dark/light
box test. No genotype effect was observed on the time spend
in the light compartment [Figure 5E; ANOVA, main effect of
genotype: F(3, 86) = 2.170, P = 0.0975]. No significant difference
between Htr1a knockout animals with or without the Cre trans-
gene was detected, arguing against an effect of this transgene on
anxiety behavior under our testing conditions. Also no behavioral
difference between Htr1acR/cR animals and constitutive knock-
out littermates (Htr1aKO/KO) was observed, suggesting that the
relatively small difference in Htr1a expression between these lines
was not sufficient to affect the behavioral phenotypes we scored.
Moreover, a significant effect of genotype on total locomotion
and a trend for decreased anxiety (increased time spent in cen-
ter and % distance in center) was observed in cortex-specific
rescue animals (Htr1acR/cR; Emx1Cre/+) in the open field test
(Supplementary Figure S1). Because it was not possible to include
more than two alleles of Htr1a in the breeding, we were not able
to directly compare the behavior of cortex-specific rescue mice
to wild-type littermates. However, behavioral testing of wild-type
and constitutive Htr1a knockout littermates deriving from a sep-
arate breeding confirmed the anxiety phenotype of the knockout
mice (Ramboz et al., 1998; Bonasera and Tecott, 2000; Ase et al.,
2002; Toth, 2003; Piszczek et al., 2013) under the breeding and
testing conditions used in this study (Supplementary Figure S2).
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FIGURE 4 | Selective rescue of Htr1a expression in cortex. (A)
Representative autoradiographs of 125I-MPPI binding to coronal mouse
brain sections containing septum, hippocampus, and raphe nuclei from
control (Htr1acR/cR) and adult cortex rescue (Htr1acR/cR ; Emx1Cre/+). (B)
Representative autoradiographs of 125I-MPPI binding to coronal mouse
brain sections containing septum, hippocampus, and raphe nuclei from
control (Htr1acR/cR) and cortical rescue (Htr1acR/cR; Emx1Cre/+) mice at
postnatal day 15. (C) Quantification of normalized 125I-MPPI signal in
auditory cortex (Cortex), CA1 hippocampus (Hippocampus), and dorsal
raphe (Raphe) confirmed tissue-specific rescue of Htr1a expression in
cortex and hippocampus in adult animals (N = 5–8, mean ± SEM,
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001; asterisks above bars indicate P-value
vs. wild-type).
Finally, no genotype effect was seen on time spent immobile in the
tail suspension test [Figure 6; ANOVA, main effect of genotype:
F(3, 108) = 0.8438, P = 0.4728]. Together these data demonstrate
that increased expression of Htr1a in cortical structures is suffi-
cient to induce reduced anxiety behavior.
DISCUSSION
Here we showed that selectively increasing Htr1a expression in
cortical principal neurons using a novel Cre-inducible rescue
allele of Htr1a is sufficient to decrease anxiety behavior in mice.
The results presented in this work support our previous findings
arguing for a role of forebrain Htr1a receptors in the modula-
tion of anxiety (Gross et al., 2002). This, taken together with data
showing that genetic suppression of Htr1a expression in sero-
tonin neurons, but not forebrain is sufficient to increase anxiety
(Richardson-Jones et al., 2011; Donaldson et al., 2014) and that
selective rescue of the receptor in serotonin neurons does not res-
cue the knockout phenotype (Piszczek et al., 2013), argues for
an interaction between forebrain and non-forebrain receptors in
regulating this phenotype (Piszczek et al., 2013).
Several features of our Cre-inducible Htr1a allele contributed
to our results. First, Cre-induced Htr1a expression is under the
control of the endogenous Htr1a promoter and was restricted
to the endogenous expression pattern (Figure 2) and cell-types
(Figure 3). This is an improvement on our previousHtr1a genetic
rescue strategy (Gross et al., 2002) that relied on the Camk2a pro-
moter and was associated with both over-expression and ectopic
expression of Htr1a. Second, Htr1acR mice exhibited low, but
significant levels of Htr1a expression (Figures 2, 4) that allowed
us to examine the effect of raising Htr1a protein levels, rather
than restoring it to mice with no endogenous receptor expression.
Arguably, this is a more subtle manipulation of Htr1a recep-
tor levels that may have facilitated our ability to elicit changes
in anxiety behavior that depend, for example, on autoreceptor
expression. Interestingly, we found that Htr1acR/cR mice were
indistinguishable from knockout mice in our behavioral tests.
Although the Htr1a knockout allele is dosage sensitive (Ramboz
et al., 1998) and heterozygous mice show intermediate levels of
protein expression as well as behavior. Our findings suggest that
the small difference in gene expression between Htr1acR/cR and
Htr1aKO/KO mice was not sufficient to affect the behavioral phe-
notypes we measured. Third, the Cre-dependence of our Htr1a
allele allowed us to use the Emx1-Cre transgene to drive rescue of
Htr1a selectively in principal cortical neurons (Figure 4). Htr1a
has been shown to be expressed not only in glutamatergic prin-
cipal cells in cortex, hippocampus, and amygdala (Aznar et al.,
2003; Santana et al., 2004; Palchaudhuri and Flügge, 2005; De
Almeida and Mengod, 2008; Marvin et al., 2010), but also in
GABAergic interneurons in these structures (Aznar et al., 2003;
Santana et al., 2004; De Almeida andMengod, 2008). Others have
shown, that decreasing the expression on the excitatory principal
neurons, but not interneurons, does not affect anxiety behavior,
but leads to depression-like behavior (Richardson-Jones et al.,
2011). Our approach allowed us to define more precisely the
cell-types involved in anxiety modulation by Htr1a, excluding a
role for non-cortical structures as well as cortical interneurons,
showing that increasing the expression on the principal cells,
but not interneurons, decreases anxiety levels without affecting
depression-like behavior. Taken together these data suggest differ-
ent and/or compensatory role of the two subpopulations of Htr1a
heteroreceptor on both anxiety and depression-like behaviors.
Our failure to observe a change in depression-related behav-
ior in the tail-suspension test was likely due to the absence of
a phenotype in our knockout mice under these test conditions.
Several other studies have reported decreased immobility in the
forced swim and tail suspension test in Htr1a knockout mice
(Ramboz et al., 1998; Mayorga et al., 2001). It is unclear why
we did not replicate this finding in our mice, but differences in
strain or testing procedure may have contributed. Despite ear-
lier reports to the contrary (Cao and Li, 2002), we did not see
any alterations in anxiety behavior associated with the Emx1-Cre
allele on the knockout background (Figure 5). This argues against
a contribution of the Cre driver line (via Emx1 heterozygosity or
linked-polymorphisms) in the decreased anxiety observed in the
cortical rescue mice.
In conclusion, our data support an anxiolytic role for Htr1a
expressed on neocortical (including cortical-related nuclei such
as basolateral amygdala) and hippocampal (archicortex) principal
cells, consistent with a role for cortical structures in modulating
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FIGURE 5 | Decreased anxiety in cortex rescue animals. Testing of
control (Htr1acR/cR), cortical rescue (Htr1acR/cR; Emx1Cre/+), knockout
(Htr1aKO/KO), and knockout mice carrying the Emx1-Cre allele
(Htr1aKO/KO; Emx1Cre/+) in the elevated plus (top row) and dark/light
(bottom row) tests. No significant effect of genotype was seen on (A)
total locomotion in the elevated plus maze. However, cortical rescue
mice showed a significant increase in (B) time in the open arms and (C)
head dips in the elevated-plus maze when compared to all other groups
(Htr1acR/cR, N = 27; Htr1acR/cR; Emx1Cre/+, N = 25; Htr1aKO/KO, N = 35;
Htr1aKO/KO; Emx1Cre/+, N = 25). Cortical rescue mice also showed a
significant increase in (D) distance in the light compartment and a trend
for an increase in (E) time in the light compartment and (F) entries into
the light compartment in the dark/light test when compared to all other
groups (Htr1acR/cR, N = 25; Htr1acR/cR; Emx1Cre/+, N = 25;Htr1aKO/KO,
N = 22; Htr1aKO/KO; Emx1Cre/+, N = 18; mean ± SEM ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001).
FIGURE 6 | No change in immobility in cortex rescue mice. No
significant effect of genotype was seen on immobility in the tail suspension
test in control (Htr1acR/cR, N = 27), cortical rescue (Htr1acR/cR; Emx1Cre/+,
N = 25), knockout (Htr1aKO/KO, N = 35), and knockout mice carrying the
Emx1-Cre allele (Htr1aKO/KO; Emx1Cre/+, N = 25; mean ± SEM).
anxiety. Earlier data showed that the Htr1a knockout phenotype
depends on Htr1a expression during the early postnatal period
when it is able to exert an influence on dendritic branching by
modulating actin-dependent growth cone dynamics in CA1 hip-
pocampal pyramidal neurons (Ferreira et al., 2010). Moreover,
our previous work suggested that the anxiety phenotype of Htr1a
knockout mice has a cognitive component that is likely to be
mediated by deficits in cortical processing of threat information
(Klemenhagen et al., 2006; Tsetsenis et al., 2007; Lo Iacono and
Gross, 2008). Thus, increase of Htr1a expression in principal hip-
pocampal neurons may be involved in the reduction of anxiety
levels in our mice, as supported by data demonstrating a function
of the hippocampus in encoding the probability of conditioned
stimulus association (Múnera et al., 2000) and the evaluation
of ambiguous threat cues (Tsetsenis et al., 2007). Our findings
demonstrate a role for Htr1a heteroreceptors in the develop-
mental programming of cortical circuits in such a way so as to
positively bias the evaluation of threats. Negative threat bias has
been described as a major component of neuroticism as well as
mood disorders (Roy et al., 2008; Armstrong and Olatunji, 2012;
Maalouf et al., 2012; Hommer et al., 2014) and defining genetic
modulators of the relevant brain regions in mice may help to
better define anxiety-related mental traits in humans with the
long-term goal of identifying targeted therapeutic interventions.
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